Skip to main content
A

AVECHO BIOTECHNOLOGY LIMITED — Investor Relations & Filings

Ticker · AVE ISIN · AU0000047441 LEI · 529900FA9G9T82C2LV25 ASX Manufacturing
Filings indexed 864 across all filing types
Latest filing 2025-04-15 Regulatory Filings
Country AU Australia
Listing ASX AVE

About AVECHO BIOTECHNOLOGY LIMITED

https://avecho.com.au/

Avecho Biotechnology Limited develops and commercializes human and animal health products using its proprietary drug delivery system, Tocopheryl Phosphate Mixture (TPM®). Derived from Vitamin E, TPM® is designed to enhance the solubility and absorption of active ingredients through the skin and digestive tract. The company focuses on applying this technology to pharmaceuticals, nutraceuticals, and animal health sectors. A primary area of development includes medicinal cannabis, where Avecho has produced high-bioavailability cannabidiol (CBD) softgel capsules for therapeutic use. The company’s portfolio also includes applications in pain management and dermatology, leveraging TPM® to improve the delivery of poorly soluble molecules and enhance the efficacy of existing treatments.

Recent filings

Filing Released Lang Actions
Section 708A Cleansing Statement 1 page 99.4KB
Regulatory Filings
2025-04-15 English
Application for quotation of securities - AVE 7 pages 21.2KB
Regulatory Filings
2025-04-15 English
Avecho receives initial US$3M upfront payment from Sandoz 3 pages 205.6KB
Regulatory Filings
2025-03-27 English
Avecho to present at NWR Virtual Healthcare Conference 2 pages 149.2KB
Regulatory Filings
2025-03-12 English
Annual Report 31 December 2024 55 pages 2.1MB
Regulatory Filings
2025-03-06 English
Appendix 4G and Corporate Governance Statement 25 pages 816.9KB
Regulatory Filings
2025-03-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.